ClinicalTrials.Veeva

Menu

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Not yet enrolling

Conditions

Advanced Cancer
Pain

Treatments

Behavioral: I-STAMP

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.

Full description

The goal of this study is to develop and refine I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), an electronic health record-integrated mobile health (mHealth) application designed to support advanced cancer patients and care teams in pain management.

The research study procedures include screening for eligibility, surveys, and interviews. It is expected that up to 73 participants will take part in this research study. Activities 1-3 are non-interventional and will be used to collect data for application development.

Activity 4: This activity will be interventional and will be added with a future amendment.

Enrollment

73 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Participants (Activities 1a, 2a, 3a):

  • Age ≥ 21 years
  • Current or previous diagnosis of advanced cancer
  • Current or previous experience with cancer pain

Exclusion Criteria for Participants (Activities 1a, 2a, 3a):

  • Inability to understand, speak, or read English
  • Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

73 participants in 1 patient group

I-STAMP Testing
Experimental group
Description:
Study procedures will be conducted as follows: Activities 1-3: Data Collection for application development Activity 4: To be added with future amendment
Treatment:
Behavioral: I-STAMP

Trial contacts and locations

1

Loading...

Central trial contact

Andrea Enzinger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems